Efsubaglutide Alfa

efsubaglutide alfa · Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Efsubaglutide Alfa, covering 2025-04-02 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Bridging Study of Efsubaglutide Alfa in Healthy Adults in Brazil [Phase 1]